GNH USA

Europe — EMA

Letrozolo Alter

GNH USA supplies Letrozolo Alter (Letrozole), an aromatase inhibitor for postmenopausal hormone receptor‑positive breast cancer.

Letrozole

Request sourcing

1
Pack/s

What is Letrozole?

Letrozole, the active ingredient in Letrozolo Alter, is an aromatase inhibitor presented as an oral tablet for oral use. It treats postmenopausal hormone receptor‑positive breast cancer by lowering estrogen production. GNH USA supplies Letrozolo Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Letrozole used for?

Letrozole is used in endocrine therapy for hormone‑dependent breast cancer.

Postmenopausal hormone receptor‑positive breast cancer: reduces tumor growth by lowering circulating estrogen levels. Adjuvant therapy: decreases the risk of disease recurrence after surgery. Neoadjuvant therapy: shrinks tumors before surgical removal.

What are the side effects of Letrozole?

Common Side Effects: - Hot flashes - Joint and muscle pain - Fatigue - Nausea - Headache - Increased sweating

Serious or Rare Side Effects: - Severe liver injury - Osteoporotic fractures - Pulmonary embolism - Deep vein thrombosis - Anaphylactic reactions - Significant cholesterol elevation

What precautions apply to Letrozole?

Letrozolo Alter should be used with caution and under medical supervision. - Pregnancy: contraindicated (Category X) – avoid use in pregnant women. - Breastfeeding: not recommended – discontinue if nursing. - Liver function: monitor in patients with hepatic impairment. - Bone health: assess risk of osteoporosis and consider calcium/vitamin D supplementation. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original container, protect from moisture and light.

What does Letrozole interact with?

Letrozolo Alter may interact with several medicines.

Major Interactions (Avoid): - Estrogen replacement therapy: may diminish letrozole efficacy. - Tamoxifen: antagonistic effect on estrogen pathways. - Strong CYP2C19 inhibitors: can increase letrozole plasma concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may lower letrozole levels. - Anticoagulants (e.g., warfarin): monitor INR and bleeding risk. - Diuretics: may affect electrolyte balance and renal function.

Frequently asked questions

What is Letrozolo Alter used for?+
Letrozolo Alter contains letrozole, an aromatase inhibitor indicated for the treatment of postmenopausal women with hormone receptor‑positive breast cancer, either as adjuvant, neoadjuvant, or metastatic therapy.
How does letrozole work in the body?+
Letrozole blocks the aromatase enzyme, which converts androgens into estrogens. By inhibiting this conversion, estrogen levels fall, reducing the growth stimulus for estrogen‑dependent breast cancer cells.
What is the usual dose of Letrozolo Alter?+
The specific dose and regimen are determined by the prescribing physician based on the patient’s clinical condition, treatment stage, and individual factors. No fixed dose is provided here.
Is Letrozolo Alter safe during pregnancy or breastfeeding?+
Letrozolo Alter is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy. It is also not recommended for breastfeeding women because it may pass into breast milk and affect the infant.
How do I order Letrozolo Alter from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.
How does Letrozolo Alter compare with other breast‑cancer therapies?+
Letrozole belongs to the aromatase inhibitor class, which directly lowers estrogen production, unlike selective estrogen receptor modulators such as tamoxifen that block estrogen receptors. Aromatase inhibitors are generally preferred for postmenopausal patients due to higher efficacy in this population.
What are the storage and handling requirements for Letrozolo Alter?+
Store Letrozolo Alter at ambient temperature, below 25 °C, in the original packaging. Keep it away from moisture, direct sunlight, and excessive heat to maintain product stability.
How is Letrozolo Alter administered?+
Letrozolo Alter is taken orally, usually as a tablet swallowed with water. The exact timing (e.g., with or without food) should follow the prescribing physician’s instructions.
What are the most serious risks associated with Letrozolo Alter?+
Serious risks include severe liver injury, osteoporotic fractures, and thromboembolic events such as deep‑vein thrombosis or pulmonary embolism. Patients should be monitored regularly for signs of these conditions.
Who should not use Letrozolo Alter?+
Letrozolo Alter should not be used by pregnant women, individuals with known hypersensitivity to letrozole, or patients with severe hepatic impairment without careful monitoring. It is also contraindicated in premenopausal women unless ovarian function suppression is confirmed.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Letrozole
Route
Oral Use
Manufacturer
Laboratori Alter S.R.L.
Origin
EU

Related products